5, 6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2 (1H)-pyridinone CAS 545445-44-1

Pwodwi deskripsyon

Non pwodwi: 5, 6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2 (1H)-pyridinone CAS 545445-44-1

 

 

Synonyms:

3-Morpholino-1-(4-(2-oxopiperidin-1-yl) phenyl)-5, 6-dihydropyridin-2 (1H)-youn;

5-morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl) phenyl]-2, 3-dihydropyridin-6-yon sel;;

 

 

Chimik & pwopriyete fizik

Aparans: solid

Épreuves: ≥ 98,0%

Dansite: 1.267 g/cm3

Bouyi pwen: 624.98 ° c nan 760 mmHg

Flash pwen: 331.78 ° c

 

 

5, 6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2 (1H)-pyridinone se youn nan enpurte nan apixaban. Apixaban se yon bouch chimik oral aktivasyon Selektif X fakte inibite devlope pa Pfizer ak Bristol Myers Squibb. Nan mwa Janvye 2013, li jwenn lisans Dwog la enpote ki te soti nan eta a manje ak medikaman Dwog nan Lachin, e li te ofisyelman nan lis nan peyi Lachin nan mwa avril 2013.

 

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.

 

 

Baj popilè: 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2 (1h)-pyridinone cas 545445-44-1, manifaktire, founise, faktori, achte, nan Stock

• On: 3- (3- (Diisopropilamino) -1-phenylpropyl) -4-hydroxybenzaldehyde CAS 214601-15-7
• Pwochen: 6-Amino-2,3-Dihydro-indol-1-karboksilik Asid Tert-butylester CAS 129488-00-2